Laboratory Tested Products (119 Offers)
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: THYMOSIN BETA-4
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 2.5-3 DAYS
DOSAGE: MEN 7.66 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PEPTIDE HORMONES
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: TB 500: 2-3 DAYS; BPC 157: 4-6 HOURS
DOSAGE: 2-6 MG PER WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS x 40 MCG
ACTIVE HALF-LIFE: 48-72 HOURS
DOSAGE: MEN 40-160 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST (FAT BURNER)
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS × 40 MCG
ACTIVE HALF-LIFE: 36–48 HOURS
DOSAGE: MEN 120–140 MCG/DAY, WOMEN 80–100 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS x 40 MCG
ACTIVE HALF-LIFE: ~36 HOURS
DOSAGE: MEN 20–120 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: SEXUAL DYSFUNCTION PEPTIDE
ACTIVE SUBSTANCE: BREMELANOTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2.7 HOURS
DOSAGE: 1–2 MG AS NEEDED
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MULTI-AGONIST PEPTIDE (GLP-1, GIP, GLUCAGON)
ACTIVE SUBSTANCE: RETATRUTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 6–7 DAYS
DOSAGE: 0.5–12 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: NOOTROPIC & ANXIOLYTIC PEPTIDE
ACTIVE SUBSTANCE: SELANK
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 3–10 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 7 DAYS
DOSAGE: 0.25–2.4 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: DUAL GIP/GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 5 DAYS
DOSAGE: 2.5–5 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
